Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 213

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Dihydromyricetin As a Novel Anti-Alcohol Intoxication Medication

Open access
Shen, Yi, Lindemeyer, A. Kerstin, Gonzalez, Claudia, Shao, Xuesi M., Spigelman, Igor, Olsen, Richard W., Liang, Jing · 2012 · The Journal of Neuroscience

Abstract

Alcohol use disorders (AUDs) constitute the most common form of substance abuse. The development of AUDs involves repeated alcohol use leading to tolerance, alcohol withdrawal syndrome, and physical and psychological dependence, with loss of ability to control excessive drinking. Currently there is no effective therapeutic agent for AUDs without major side effects. Dihydromyricetin (DHM; 1 mg/kg, i.p. injection), a flavonoid component of herbal medicines, counteracted acute alcohol (EtOH) intoxication, and also withdrawal signs in rats including tolerance, increased anxiety, and seizure susceptibility; DHM greatly reduced EtOH consumption in an intermittent voluntary EtOH intake paradigm in rats. GABA A receptors (GABA A Rs) are major targets of acute and chronic EtOH actions on the brain. At the cellular levels, DHM (1 μ m ) antagonized both acute EtOH-induced potentiation of GABA A Rs and EtOH exposure/withdrawal-induced GABA A R plasticity, including alterations in responsiveness of extrasynaptic and postsynaptic GABA A Rs to acute EtOH and, most importantly, increases in GABA A R α4 subunit expression in hippocampus and cultured neurons. DHM anti-alcohol effects on both behavior and CNS neurons were antagonized by flumazenil (10 mg/kg in vivo ; 10 μ m in vitro ), the benzodiazepine (BZ) antagonist. DHM competitively inhibited BZ-site [ 3 H]flunitrazepam binding (IC 50 , 4.36 μ m ), suggesting DHM interaction with EtOH involves the BZ sites on GABA A Rs. In summary, we determined DHM anti-alcoholic effects on animal models and determined a major molecular target and cellular mechanism of DHM for counteracting alcohol intoxication and dependence. We demonstrated pharmacological properties of DHM consistent with those expected to underlie successful medical treatment of AUDs; therefore DHM is a therapeutic candidate.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.4639-11.2012

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 213

Metadata

Authors
Shen, Y., Lindemeyer, A. K., Gonzalez, C., Shao, X. M., Spigelman, I., Olsen, R. W., & Liang, J.
Venue
The Journal of Neuroscience
Published
2012-01-04
Volume
32
Issue
1
Pages
390-401
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2157175793
Cited by
213
References
4
FWCI
36.45
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dihydromyricetin As a Novel Anti-Alcohol Intoxication Medication. https://app.cochat.ai/papers/10.1523/jneurosci.4639-11.2012
The paper
Shen, Y., Lindemeyer, A. K., Gonzalez, C., Shao, X. M., Spigelman, I., Olsen, R. W., & Liang, J. (2012). Dihydromyricetin As a Novel Anti-Alcohol Intoxication Medication. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.4639-11.2012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.